http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-122280-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8281ac9f4fb11f15a5da018344453338
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
filingDate 2020-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feb99f6623085d9782df479b28bbf28d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8c48ee1f5fee131b3da1919ed01c61a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_017463753de5ee09808402bcae6e69ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e8a3f3873f5921eb9f57df16e0757df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad52fc00823a913987d59f842ac1652c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1fe005d41c3154be26edacca96fb01d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2be2bc851c2aa57ec707e3c97708292e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d17e526db8937a21f13361b1c917995
publicationDate 2022-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-122280-A1
titleOfInvention ANTIVIRAL HETEROCYCLIC COMPOUNDS
abstract The present invention discloses compounds of formula (1), or pharmaceutically acceptable salts, esters or precursor drugs thereof, which inhibit Human Respiratory Syncytial Virus (HRSV) or inhibitors of Human Metapneumovirus (HMPV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from an HRSV or HMPV infection. The invention also relates to methods of treating an HRSV or HMPV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
priorityDate 2019-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283

Total number of triples: 24.